Pediatrix Medical (MD) EBIT (2009 - 2026)

Pediatrix Medical (MD) has 18 years of EBIT data on file, last reported at $41.7 million in Q1 2026.

• EBIT for Q1 2026 came in at $41.7 million, up 29.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $55.0 million (up 204.77% YoY), and the FY2025 annual result was $45.5 million, up 166.15% from the prior year.
• EBIT advanced to $41.7 million in Q1 2026 per MD's latest filing, from -$114.6 million in the prior quarter.
• Over five years, EBIT peaked at $68.1 million in Q3 2025 and troughed at -$157.7 million in Q2 2024.
• A 5-year average of $11.7 million and a median of $39.1 million in 2022 frame the typical range for EBIT.
• The sharpest annual moves came in 2024 and 2025: EBIT plunged 425.22% in 2024, then jumped 137.96% in 2025.
• A 5-year view of EBIT shows it stood at $36.0 million in 2022, then sank by 409.37% to -$111.5 million in 2023, then jumped by 135.24% to $39.3 million in 2024, then plunged by 391.59% to -$114.6 million in 2025, then surged by 136.36% to $41.7 million in 2026.
• Business Quant data shows MD's EBIT at $41.7 million in Q1 2026, -$114.6 million in Q4 2025, and $68.1 million in Q3 2025.